Skip to content 
Lakewood-amedex Biotherapeutics Inc is a pharmaceutical company. The Company is focused on addressing unmet needs in the treatment of serious infectious diseases, improving patient outcomes, and significantly reducing the threat posed by antibiotic-resistant bacterial strains like MRSA, NDM-1, and many others. The Company is engaged in development of its Bisphosphocin class of antimicrobial agents. The Company is exploring additional local drug delivery applications, including complicated urinary tract infections (CAUTI) and pulmonary infections. The Company has a portfolio of compounds that are being profiled for indications such as infected diabetic foot ulcer, urinary tract infections, and pulmonary infections. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| LABT | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| LABT | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) share price today is $0.706
Yes, Indians can buy shares of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) on Vested. To buy
Yes, you can purchase fractional shares of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) via the Vested app. You can start investing in LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) with a minimum investment of $1.
You can invest in shares of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) via Vested in three simple steps:
The 52-week high price of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is $. The 52-week low price of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is $.
The price-to-earnings (P/E) ratio of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is
The price-to-book (P/B) ratio of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is 0.00
The dividend yield of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is 0.00%
The market capitalization of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) is $10.50M
The stock symbol (or ticker) of LAKEWOOD-AMEDEX BIOTHERAPEUT is LABT
Consider the share price of LAKEWOOD-AMEDEX BIOTHERAPEUT as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether LAKEWOOD-AMEDEX BIOTHERAPEUT has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in LAKEWOOD-AMEDEX BIOTHERAPEUT shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the LAKEWOOD-AMEDEX BIOTHERAPEUT stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of LAKEWOOD-AMEDEX BIOTHERAPEUT and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that LAKEWOOD-AMEDEX BIOTHERAPEUT stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
